203 related articles for article (PubMed ID: 30478976)
1. When pharmacology meets the microbiome: new targets for therapeutics?
Hyland NP; Cryan JF
Br J Pharmacol; 2018 Dec; 175(24):4401-4403. PubMed ID: 30478976
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the commensal microbiota to atherosclerosis and arterial thrombosis.
Kiouptsi K; Reinhardt C
Br J Pharmacol; 2018 Dec; 175(24):4439-4449. PubMed ID: 30129122
[TBL] [Abstract][Full Text] [Related]
3. Drug-gut microbiota interactions: implications for neuropharmacology.
Walsh J; Griffin BT; Clarke G; Hyland NP
Br J Pharmacol; 2018 Dec; 175(24):4415-4429. PubMed ID: 29782640
[TBL] [Abstract][Full Text] [Related]
4. Finding the needle in the haystack: systematic identification of psychobiotics.
Bambury A; Sandhu K; Cryan JF; Dinan TG
Br J Pharmacol; 2018 Dec; 175(24):4430-4438. PubMed ID: 29243233
[TBL] [Abstract][Full Text] [Related]
5. Molecular pharmacology of GPCRs.
Langmead CJ; Summers RJ
Br J Pharmacol; 2018 Nov; 175(21):4005-4008. PubMed ID: 30302756
[TBL] [Abstract][Full Text] [Related]
6. Microbial biotransformations in the human distal gut.
Bik EM; Ugalde JA; Cousins J; Goddard AD; Richman J; Apte ZS
Br J Pharmacol; 2018 Dec; 175(24):4404-4414. PubMed ID: 29116650
[TBL] [Abstract][Full Text] [Related]
7. Emerging areas of opioid pharmacology.
Kelly E; Henderson G; Bailey CP
Br J Pharmacol; 2018 Jul; 175(14):2715-2716. PubMed ID: 29939423
[TBL] [Abstract][Full Text] [Related]
8. Drug metabolism and antibiotic resistance in micro-organisms.
Sim E; Ryan A
Br J Pharmacol; 2017 Jul; 174(14):2159-2160. PubMed ID: 28463394
[TBL] [Abstract][Full Text] [Related]
9. Spotlight on small molecules in cardiovascular diseases.
Wang X; Huang Y; Ji Y
Br J Pharmacol; 2018 Apr; 175(8):1111-1113. PubMed ID: 29574891
[TBL] [Abstract][Full Text] [Related]
10. Highlights into the pharmacology of nutraceuticals.
Andrew R; Izzo AA
Br J Pharmacol; 2020 Mar; 177(6):1209-1211. PubMed ID: 32133625
[TBL] [Abstract][Full Text] [Related]
11. Targeting inflammation to reduce cardiovascular disease risk.
Maffia P; Cirino G
Br J Pharmacol; 2017 Nov; 174(22):3895-3897. PubMed ID: 29080212
[TBL] [Abstract][Full Text] [Related]
12. Inventing new therapies without reinventing the wheel: the power of drug repurposing.
Papapetropoulos A; Szabo C
Br J Pharmacol; 2018 Jan; 175(2):165-167. PubMed ID: 29313889
[TBL] [Abstract][Full Text] [Related]
13. Nicotinic acetylcholine receptors.
Wonnacott S; Bermudez I; Millar NS; Tzartos SJ
Br J Pharmacol; 2018 Jun; 175(11):1785-1788. PubMed ID: 29878346
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of cognition: a panacea for neuropsychiatric disease?
Bailey SJ; Neill JC; Moran PM
Br J Pharmacol; 2017 Oct; 174(19):3133-3135. PubMed ID: 28901012
[TBL] [Abstract][Full Text] [Related]
15. The importance of sex differences in pharmacology research.
Gogos A; Langmead C; Sullivan JC; Lawrence AJ
Br J Pharmacol; 2019 Nov; 176(21):4087-4089. PubMed ID: 31769019
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial pharmacology: featured mechanisms and approaches for therapy translation.
Wang X; Galli G; Campanella M
Br J Pharmacol; 2019 Nov; 176(22):4245-4246. PubMed ID: 31793696
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in targeting ion channels to treat chronic pain.
Stevens EB; Stephens GJ
Br J Pharmacol; 2018 Jun; 175(12):2133-2137. PubMed ID: 29878335
[TBL] [Abstract][Full Text] [Related]
18. Nutraceuticals as modulators of gut microbiota: Role in therapy.
Quigley EMM
Br J Pharmacol; 2020 Mar; 177(6):1351-1362. PubMed ID: 31659751
[TBL] [Abstract][Full Text] [Related]
19. The roles of gut microbiota and circadian rhythm in the cardiovascular protective effects of polyphenols.
Man AWC; Xia N; Daiber A; Li H
Br J Pharmacol; 2020 Mar; 177(6):1278-1293. PubMed ID: 31465555
[TBL] [Abstract][Full Text] [Related]
20. Molecular pharmacology of G protein-coupled receptors.
Summers RJ
Br J Pharmacol; 2016 Oct; 173(20):2931-3. PubMed ID: 27682321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]